Sponsor or institution
Clinical trials and research at Spring Mill Pharma Incorporated
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $2.4 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
New antibiotic approach to fight resistant gut bacteria (β-lactamase producing CRE)
A new class of compounds that blocks bacterial enzymes and allows treating infections caused by highly resistant Enterobacterales.
-
New non-β-lactam compounds to tackle drug-resistant Pseudomonas infections
A small business project tests new non-β-lactam compounds that block penicillin-binding proteins in multidrug-resistant Pseudomonas aeruginosa to develop stronger antibiotics.
-
New cyclic boronate antibiotics to fight carbapenem-resistant Acinetobacter baumannii
A new class of targeted antibiotic compounds is being developed to treat serious infections caused by carbapenem-resistant Acinetobacter baumannii.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.